Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas.

OBJECTIVE: To evaluate sex differences in liver metastases at diagnosis across major gastrointestinal adenocarcinomas and assess variation by primary site and age. DESIGN, SETTING, AND PARTICIPANTS: Population-based cross-sectional study using Surveillance, Epidemiology, and End Results data (2012-2022). Patients aged 15 years or older with colorectal, esophagogastric, pancreatic, or biliary adenocarcinoma and known status of liver metastasis at diagnosis were selected. Patients with concurrent extrahepatic metastases were included. EXPOSURE: Sex and age. MAIN OUTCOMES AND MEASURES: Prevalence of synchronous liver metastases documented at diagnosis. Prevalence ratios (PRs) were estimated using modified Poisson regression with robust variance, adjusting for age, primary site, and year of diagnosis. Effect modification by primary site and age was assessed. RESULTS: Among 410,439 patients, the overall prevalence of liver metastases was 22.2% and higher in males than females (23.5% vs 20.6%). Female sex was associated with a lower prevalence of liver metastases (adjusted PR 0.86; 95% CI, 0.85-0.87; P < 0.001). Effect modification by primary site was observed (P for interaction < 0.001): females had lower prevalence in colorectal (PR 0.84), esophagogastric (PR 0.69), and pancreatic (PR 0.89), higher prevalence in extrahepatic biliary (PR 1.14), and no significant difference in intrahepatic biliary cancers (PR 1.04). There was also evidence of effect modification by age (P for interaction < .001), with sex differences in liver metastasis prevalence attenuating across older age groups. CONCLUSIONS AND RELEVANCE: Sex differences in liver metastases at diagnosis vary by primary site and age across gastrointestinal adenocarcinomas. Female sex is associated with lower prevalence of liver metastases in most tumor types, particularly in early-onset disease, except extrahepatic biliary cancers. These findings highlight sex as a clinically relevant variable associated with metastatic presentation.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1093/oncolo/oyag437
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas.

Cathy Eng, Nadia Kirmani, Rishi Parikh, Rania Abdusamad et al.
2 links
PubMed
Colorectal Cancer Treatments and Studies
article

Sex Differences in Liver Metastases at Diagnosis Across Early- and Average-Onset Gastrointestinal Adenocarcinomas.

Cathy Eng, Nadia Kirmani, Rishi Parikh, Rania Abdusamad, Adhvaith Balakrishnan, Shruti Patel, George Fisher
article en

Abstract

OBJECTIVE: To evaluate sex differences in liver metastases at diagnosis across major gastrointestinal adenocarcinomas and assess variation by primary site and age. DESIGN, SETTING, AND PARTICIPANTS: Population-based cross-sectional study using Surveillance, Epidemiology, and End Results data (2012-2022). Patients aged 15 years or older with colorectal, esophagogastric, pancreatic, or biliary adenocarcinoma and known status of liver metastasis at diagnosis were selected. Patients with concurrent extrahepatic metastases were included. EXPOSURE: Sex and age. MAIN OUTCOMES AND MEASURES: Prevalence of synchronous liver metastases documented at diagnosis. Prevalence ratios (PRs) were estimated using modified Poisson regression with robust variance, adjusting for age, primary site, and year of diagnosis. Effect modification by primary site and age was assessed. RESULTS: Among 410,439 patients, the overall prevalence of liver metastases was 22.2% and higher in males than females (23.5% vs 20.6%). Female sex was associated with a lower prevalence of liver metastases (adjusted PR 0.86; 95% CI, 0.85-0.87; P < 0.001). Effect modification by primary site was observed (P for interaction < 0.001): females had lower prevalence in colorectal (PR 0.84), esophagogastric (PR 0.69), and pancreatic (PR 0.89), higher prevalence in extrahepatic biliary (PR 1.14), and no significant difference in intrahepatic biliary cancers (PR 1.04). There was also evidence of effect modification by age (P for interaction < .001), with sex differences in liver metastasis prevalence attenuating across older age groups. CONCLUSIONS AND RELEVANCE: Sex differences in liver metastases at diagnosis vary by primary site and age across gastrointestinal adenocarcinomas. Female sex is associated with lower prevalence of liver metastases in most tumor types, particularly in early-onset disease, except extrahepatic biliary cancers. These findings highlight sex as a clinically relevant variable associated with metastatic presentation.

PubMed
Vanderbilt University (US), Stanford Health Care (US), Stanford Medicine (US), Vanderbilt-Ingram Cancer Center (US), Stanford University (US)
Good health and well-being, Reduced inequalities
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon